Glaukos Corp share price logo

Glaukos Corp Share Price

NYSE: GKOS

Mid Cap

$103.17

-4.58

(-4.25%)

as on

Glaukos Corp Stock Performance

as on March 28, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $102.12
    $106.52
    downward going graph

    1.02%

    Downside

    3.25%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $73.16
    $130.23
    downward going graph

    29.09%

    Downside

    26.23%

    Upside

    downward going graph

Glaukos Corp share price movements today

Previous Close
$107.75
Open
$106.52
Volume
453.2K
Day's Low - High
$102.12 - $106.52
52 Week Low - High
$73.16 - $130.23

Glaukos Corp Historical Returns

1 Month Return
-14.3 %
3 Month Return
-11.21 %
1 Year Return
+ 1.16 %
3 Year Return
+ 108.19 %
5 Year Return
+ 20.57 %

Glaukos Corp Stock Fundamentals & Key Indicators

Check Glaukos Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.3B

EPS (TTM)

-0.5428

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

18.96%

PE Ratio (TTM)

-45.94

Industry PE ratio

7.887522123893805

PEG Ratio

1.64

EBITDA

-48.6M

Revenue (TTM)

507.4M

Profit Margin

-36.99%

Return On Equity TTM

-26.38%

Glaukos Corp Stock Valuation

Track how Glaukos Corp P/E has moved over time to understand its valuation trends.

Glaukos Corp in the last 5 years

  • Overview

  • Trends

Lowest (-190.97x)

June 30, 2021

Today (-45.94x)

March 28, 2026

Industry (7.89x)

March 28, 2026

Highest (-20.23x)

March 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -45.94x

Glaukos Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Glaukos Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Glaukos Corp image
Glaukos Corp
BUY$6.3B20.57%-45.94-36.99%
Boston Scientific Corp. image
Boston Scientific Corp.
BUY$104.3B80.98%36.1714.44%
Stryker Corporation image
Stryker Corporation
BUY$127.4B35.88%39.712.92%
Medtronic Plc image
Medtronic Plc
BUY$112.6B-26.5%24.4913.00%
Abbott Laboratories image
Abbott Laboratories
BUY$181.7B-14.81%28.1114.72%
See all

Stock Returns calculator for Glaukos Corp Stock including INR - Dollar returns

The Glaukos Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Glaukos Corp investment value today

Current value as on today

₹1,12,000

Returns

₹12,000

(+12%)

Returns from Glaukos Corp Stock

₹1,147 (+1.15%)

Dollar Impact

₹10,853 (+10.85%)

Analyst Recommendation on Glaukos Corp Stock

Based on 20 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 20 analysts, 75% of analysts recommend a 'BUY' rating for Glaukos Corp. Average target price of $138.75

Glaukos Corp Share Price Target

Get share price movements and forecasts by analysts on Glaukos Corp.

What analysts predicted

25.64%UPSIDE

Target Price

$138.75

Current Price

$103.17

Analyzed by

20 Analysts

Target

$138.75

Glaukos Corp target price $138.75, a slight upside of 25.64% compared to current price of $103.17. According to 20 analysts rating.

Glaukos Corp Stock’s Investor Sentiment and Interest

Search interest for Glaukos Corp Stock has increased by 21% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:21% versus previous 30 day period

Glaukos Corp Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
78
82
85
95
96
105
106
124
133
143
Gross Profit
59
63
65
73
74
76
82
97
104
119
Operating Income
-28
-38
-39
-29
-24
-28
-20
-22
-16
-18
EBITDA
-15
-23
-27
-36
-9
-22
-7
-8
0
-129
Interest Expense
3
3
3
3
1
1
1
1
5
1
Depreciation
11
9
9
7
12
9
9
9
10
13
Income Before Tax
-30
-36
-40
-50
-21
-33
-17
-19
-15
-139
Income Tax Expense
0
0
0
0
0
0
0
0
0
-6
Net Income
-30
-36
-40
-50
-21
-33
-18
-19
-16
-133
Net Profit Margin
-39.01%
-44.65%
-47.70%
-52.82%
-22.15%
-31.83%
-17.01%
-15.84%
-12.15%
-93.39%

Glaukos Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
114
159
181
236
224
294
282
314
383
507
Gross Profit
98
138
156
198
133
227
213
239
289
282
Operating Income
4
-2
-13
-50
-123
-32
-82
-128
-122
-199
EBITDA
8
5
-6
-37
-83
-1
-48
-82
-95
-150
Interest Expense
0
0
-
2
14
13
13
13
10
4
Depreciation
-
5
6
9
34
34
35
37
39
42
Income Before Tax
4
0
-12
-50
-132
-49
-98
-133
-145
-193
Income Tax Expense
0
0
0
-65
-11
0
0
0
0
-5
Net Income
4
0
-12
15
-120
-49
-99
-134
-146
-187
Net Profit Margin
3.95%
-0.06%
-7.14%
6.51%
-53.50%
-16.87%
-35.07%
-42.79%
-38.17%
-36.99%

Glaukos Corp Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-36
-40
-50
-21
-33
-18
-19
-16
-133
Operating Cash Flow
-10
-33
-18
-9
0
-18
6
-10
6
Investing Cash Flow
-12
-29
34
30
11
-36
-20
-3
-15
Financing Cash Flow
7
13
8
9
60
1
2
5
2
Change in Cash
-15
-50
25
32
69
-55
-14
-2
-7

Glaukos Corp Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-12
15
-120
-49
-99
-134
-146
-133
Operating Cash Flow
25
18
0
-22
24
-33
-57
-61
-46
Investing Cash Flow
-11
-26
43
-205
-58
44
14
47
-77
Financing Cash Flow
4
21
-9
262
39
6
15
91
11
Change in Cash
18
14
32
34
4
18
-26
76
-111

Global Institutional Holdings in Glaukos Corp

Funds
Holdings
Ameriprise Financial Inc
3.27%
AllianceBernstein L.P.
2.98%
Westfield Capital Management Company, L.P.
2.04%
Millennium Management LLC
2.77%
Brown Capital Management, LLC
1.31%
See all

Glaukos Corp News & Key Events

  • img

    Today's Timeline - 30 October

    Thu, 10:25 PM

    -

    Glaukos posts narrower Q3 loss and beats revenue estimates, guiding for FY25 sales of $490-$495 million.

Insights on Glaukos Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, GKOS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 10 quarters, 78.04M → 143.12M (in $), with an average increase of 6.4% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, GKOS stock has moved up by 26.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp. has given 11.9% return, outperforming this stock by 10.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -16.23M → -133.65M (in $), with an average decrease of 723.5% per quarter

About Glaukos Corp

glaukos corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world’s leading causes of blindness. glaukos has pioneered micro-invasive glaucoma surgery, or migs, to revolutionize the traditional glaucoma treatment and management paradigm. the company launched the istent trabecular micro-bypass stent, its first migs device, in the united states in 2012. glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. glaukos believes the istent is the smallest medical device ever approved by the food and drug administration, or fda, measuring 1.0 mm long and 0.33 mm wide. in june 2015, the company completed an initial public offering and its shares are now traded on the new york stock exchange unde
OrganisationGlaukos Corp
HeadquartersOne Glaukos Way, Aliso Viejo, CA, United States, 92656
IndustryHealth Technology
CEOMr. Thomas William Burns
E-voting on sharesClick here to vote

Key Management of Glaukos Corp

Name

Title

Mr. Thomas William Burns

Chairman & CEO

Mr. Joseph E. Gilliam

President & COO

Mr. Alex R. Thurman

Senior VP & CFO

Dr. Tomas Navratil Ph.D.

Chief Development Officer

Mr. Christopher William Lewis

Vice President of Investor Relations & Corporate Affairs

Ms. Diana A. Scherer

VP of Compliance & Deputy General Counsel

Ms. Jane E. Rady

Senior Vice President of Corporate Strategy & Business Development

Mr. Robert L. Davis J.D.

Senior VP, General Counsel & Business Development

Ms. Michele M. Allegretto

Senior Vice President of Human Resources

Mr. L. Jay Katz FACS, M.D.

Chief Medical Officer

FAQs

What is Glaukos Corp share price today?

Glaukos Corp share price today is $103.17 as on at the close of the market. Glaukos Corp share today touched a day high of $106.52 and a low of $102.12.

What is the 52 week high and 52 week low for Glaukos Corp share?

Glaukos Corp share touched a 52 week high of $130.23 on and a 52 week low of $73.16 on . Glaukos Corp stock price today i.e. is closed at $103.17,which is 20.78% down from its 52 week high and 41.02% up from its 52 week low.

What is Glaukos Corp's market capitalisation today?

Glaukos Corp market capitalisation is $0.01T as on .

How to invest in Glaukos Corp Stock (GKOS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Glaukos Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Glaukos Corp Shares that will get you 0.0145 shares as per Glaukos Corp share price of $103.17 per share as on March 28, 2026 at 1:29 am IST.

What is the minimum amount required to buy Glaukos Corp Stock (GKOS) from India?

Indian investors can start investing in Glaukos Corp (GKOS) shares with as little as ₹94.63 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.30 in Glaukos Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Glaukos Corp share’s latest price of $103.17 as on March 28, 2026 at 1:29 am IST, you will get 0.0969 shares of Glaukos Corp. Learn more about fractional shares .

What are the returns that Glaukos Corp has given to Indian investors in the last 5 years?

Glaukos Corp stock has given 20.57% share price returns and 29.6% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?